byiShook Opinion
Feb 11, 2025 - 11:55
Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time. The post Biohaven Just Hurdled An FDA Setback — And Its Moving Lines appeared first on Investor's Business Daily.
Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.
The post Biohaven Just Hurdled An FDA Setback â And Its Moving Lines appeared first on Investor's Business Daily.